Respiratory nurse lead Carol Stonham outlines what nurses in primary care need to know about changes in the diagnosis and ...

Part two of this series sees Ravijyot Saggu explore pharmacological management recommendations from the new joint chronic ...

Ravijyot Saggu explores key updates and implications of the new joint chronic asthma guidelines for diagnosis and monitoring.

To effectively tackle anxiety, beta-blockers should be used as part of a broader treatment plan that includes talk therapy and other forms of therapy. Beta-blockers are fast-acting medications ... but ...

Over the last 10 years, the long-acting beta-agonists (LABAs) have become an important add-on therapy for the management of asthma, and they are now often used with ICS in a single ICS/LABA ...

with and without an added long-acting β-agonist (LABA). The identified signatures were then associated with longitudinal clinical variables after treatment. Differential gene expression and cellular ...

ccdhb.org.nz Methods We included peer-reviewed publications of randomised controlled trials (RCTs) that enrolled children or adults in any healthcare setting and compared epinephrine by any route to ...

Introduction Opioid agonist treatment is effective for opioid dependence and newer extended-release buprenorphine (BUP-XR) injections represent a significant development. The Community Long-Acting ...

119 A long-acting oral formulation of fasudil was recently tested in a small pilot RCT in Japan involving 23 PAH patients over 12 weeks. 120 No significant differences in pulmonary hemodynamics and ...

Background: Current guidelines recommend the use of inhaled corticosteroids (ICSs) added to long-acting β 2-agonists (LABAs ... of LABAs/ICSs compared with LABA monotherapy for patients with ...

Long-term treatment with beta-blockers may not lower the risk of death or myocardial infarction (MI) in patients with MI, a preserved left ventricular ejection fraction (LVEF) of ≥50% and coronary ...

What is the clinical and cost-effectiveness of regular 'fixed-dose' inhaled corticosteroid (ICS) regimens (using SABA [short-acting beta2 agonist] as a reliever) compared with 'as-needed' strategies ...